IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

BVF Inc

Q2 2019 Holdings

Filed 2019-08-14 | 56 holdings | $118.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↑Shares% Portfolio
Array Biopharma Inc(ARRYEUR)COM04269X105$55.3K1,193,2240.0%
Merus N VCOMN5749R100$68.0K4,639,4130.1%
Corvus Pharmaceuticals Inc(CRVS)COM221015100$10.4M2,774,7508.8%
Cytomx Therapeutics Inc(CTMX)COM23284F105$21.0M1,873,61717.7%
Arcus Biosciences Inc(RCUS)COM03969F109$28.1M3,535,22323.7%
Cytokinetics Inc(CYTK)COM NEW23282W605$58.2M5,176,87849.1%
PreviousPage 2 of 2